← FDA DRUG APPROVALS

FDA ANDA · ANDA075224

CLOBETASOL PROPIONATE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA075224
TYPE
ANDA
ORIGINAL APPROVAL
1998-11-16
LATEST ACTION
2017-01-06
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · SOLUTION · TOPICAL

Approval history

2017-01-06Labeling · Supplement 12 · standardAP
2002-12-16Manufacturing (CMC) · Supplement 2AP
2002-12-16Manufacturing (CMC) · Supplement 3AP
1999-04-09Manufacturing (CMC) · Supplement 1AP
1998-11-16OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →